Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ixazomib (ninlaro) (1 trial)
lenalidomide (revlimid) (1 trial)
progesterone (progestasert) (1 trial)
131i-lipiodol (Lipiodol) (1 trial)
alteplase (Activase) (1 trial)
epirubicin (ellence) (1 trial)
gelatin (1 trial)
nectin-4 car-t cell (1 trial)
Carcinoma, Hepatocellular (Phase 3)
Neoplasms (Phase 1)
Stroke (Phase 4)
Thrombosis (Phase 3)
Trials (5 total)
Trial APIs (8 total)